Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
NCT07308990

Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate Cancer

Led by N.N. Alexandrov National Cancer Centre · Updated on 2025-12-30

800

Participants Needed

1

Research Sites

343 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a randomized controlled study assessing outcome of low (no or limited) versus high (limited or extended) extent of lymph node dissection in addition to radical prostatectomy in patients with operable localized or locally advanced prostate cancer.

CONDITIONS

Official Title

Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate Cancer

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Age over 18 years
  • Histologically confirmed localized or locally advanced prostate cancer without neuroendocrine components
  • No evidence of metastatic tumor spread
  • Tumor is locally resectable based on digital rectal exam and/or pelvic CT or MRI
  • Suitable for radical prostatectomy considering comorbidities and life expectancy
  • Signed informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Presence of another active malignant invasive cancer
  • Contraindication to pelvic lymph node dissection such as prior pelvic radiation therapy
  • Evidence of metastases in regional lymph nodes from preoperative exams including PET/CT with PSMA
  • Severe other diseases limiting ability to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

N.N. Alexandrov National Cancer Centre

Lyasny, Minsk Oblast, Belarus, 223040

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here